These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30681304)

  • 21. The next wave of corporate medicine--how we all might benefit.
    Cutler DM
    N Engl J Med; 2009 Aug; 361(6):549-51. PubMed ID: 19657118
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmaceuticals and Medical Devices: Business Practices.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-38. PubMed ID: 28252886
    [No Abstract]   [Full Text] [Related]  

  • 23. Business of Health: Business of Healthcare.
    Berry MD;
    Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-76. PubMed ID: 28248462
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-27. PubMed ID: 18345555
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmaceuticals and Medical Devices: Business Practices.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2015 Dec; ():1-37. PubMed ID: 27116796
    [No Abstract]   [Full Text] [Related]  

  • 26. National health spending in 2011: overall growth remains low, but some payers and services show signs of acceleration.
    Hartman M; Martin AB; Benson J; Catlin A;
    Health Aff (Millwood); 2013 Jan; 32(1):87-99. PubMed ID: 23297275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prescription drug costs easier to swallow.
    State Legis; 2010 Apr; 36(4):10. PubMed ID: 20397320
    [No Abstract]   [Full Text] [Related]  

  • 28. Is a paradigm shift in US healthcare reimbursement inevitable?
    Weintraub WS; Shine K
    Circulation; 2004 Mar; 109(12):1448-55. PubMed ID: 15051648
    [No Abstract]   [Full Text] [Related]  

  • 29. Public drug expenditure in the Republic of Ireland.
    Barry M; Usher C; Tilson L
    Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):239-45. PubMed ID: 20545588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Forecasting the future.
    Tecnologica; 1999 Dec; ():1, 3-6, 14-5. PubMed ID: 10848110
    [No Abstract]   [Full Text] [Related]  

  • 31. Americans' access to prescription drugs stabilizes, 2007-2010.
    Boukus ER; Carrier ER
    Track Rep; 2011 Dec; (27):1-5. PubMed ID: 22180943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Has The Era Of Slow Growth For Prescription Drug Spending Ended?
    Aitken M; Berndt ER; Cutler D; Kleinrock M; Maini L
    Health Aff (Millwood); 2016 Sep; 35(9):1595-603. PubMed ID: 27605638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Healthcare Reform: Enforcement And Compliance.
    Berry MD;
    Issue Brief Health Policy Track Serv; 2017 Dec; 2017():1-34. PubMed ID: 29360296
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmaceuticals and Medical Devices: Cost Savings.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-31. PubMed ID: 28252884
    [No Abstract]   [Full Text] [Related]  

  • 35. National health expenditure projections, 2013-23: faster growth expected with expanded coverage and improving economy.
    Sisko AM; Keehan SP; Cuckler GA; Madison AJ; Smith SD; Wolfe CJ; Stone DA; Lizonitz JM; Poisal JA
    Health Aff (Millwood); 2014 Oct; 33(10):1841-50. PubMed ID: 25187525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementation of the biosimilar pathway: economic and policy issues.
    Grabowski H; Long G; Mortimer R
    Seton Hall Law Rev; 2011; 41(2):511-57. PubMed ID: 21739758
    [No Abstract]   [Full Text] [Related]  

  • 37. No credit due: lower spending increases are rooted in a bad economy.
    Raske K; Vladeck B
    Mod Healthc; 2012 Mar; 42(13):26. PubMed ID: 22533260
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmaceuticals and Medical Devices: Medicare Part D.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2017 Dec; 2017():1-32. PubMed ID: 29361658
    [No Abstract]   [Full Text] [Related]  

  • 40. Medicaid prescription drug coverage: state efforts to control costs.
    Gencarelli DM
    NHPF Issue Brief; 2003 May; (790):1-17. PubMed ID: 12751504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.